In addition, the three other CT antigens –GAGE, SAGE1 and Nuclear RNA export factor 2 (NXF2), were infrequently or rarely expressed, only in 3.5%, 2.2% and 1.8% of the breast cancer patients, respectively [33]. This evidence concerns the gene NXF2 and breast carcinoma.